Therefore, concerning the first step of the glutaminolysis pathway, our findings suggested that GLSiso2 plays a key role in tumorigenesis and malignant progression of astrocytoma, whereas the GLS2 expression pattern is consistent with tumor suppressor function, being mostly suppressed in the aggressive MS molecular subtype of GBM. Here, GLS2 is linked to neoplasm.